微信小陈
微信小章
产品简介
购买须知
| 产品名称： | Campylobacter lari Benjamin et al. |
|---|---|
| 商品货号： | TS151663 |
| Application： | Enteric Research Emerging infectious disease research |
| Isolation： | Human feces |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Preceptrol®： | no |
| Type Strain： | no |
| Comments： | Enteritis |
| Medium： | ATCC® Medium 1115: Brucella albimi broth ATCC® Medium 177: Fluid thioglycollate medium ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood |
| Growth Conditions： | Temperature: 37°C Atmosphere: Microaerophilic |
| Name of Depositor： | AE Simor |
| References： | Simor AE, Wilcox L. Enteritis associated with Campylobacter laridis. J. Clin. Microbiol. 25: 10-12, 1987. PubMed: 3793864 |
| Cross References： | Nucleotide (GenBank) : AX110916 Sequence 1649 from Patent WO0123604. Nucleotide (GenBank) : AX110943 Sequence 1676 from Patent WO0123604. |